Inhibikase Therapeutics Eulerpool News

Inhibikase Therapeutics Eulerpool News

Inhibikase Therapeutics Stock News

Inhibikase Therapeutics is being monitored by journalists and investors worldwide. We gather the latest Inhibikase Therapeutics news here.

• August 16 ·

  GuruFocus
  Inhibikase Therapeutics Inc (IKT) Q2 2024 Earnings Call Transcript Highlights: Improved ...
• August 15 ·

  SeekingAlpha
  Inhibikase Therapeutics, Inc. (IKT) Q2 2024 Earnings Call Transcript
• August 15 ·

  Seeking Alpha
  Inhibikase Therapeutics GAAP EPS of -$0.66 beats by $0.01
• August 14 ·

  Yahoo
  Inhibikase Therapeutics Reports Second Quarter Financial Results and Highlights Recent Period Activity
• August 14 ·

  InvestorPlace
  IKT Stock Earnings: Inhibikase Therapeutics Beats EPS for Q2 2024
• August 14 ·

  Thefly.com
  Inhibikase Therapeutics reports Q2 EPS (66c), consensus (67c)
• August 7 ·

  Yahoo
  Inhibikase Therapeutics to Report Second Quarter 2024 Financial Results on August 14, 2024
• June 18 ·

  TipRanks
  Analysts Offer Insights on Healthcare Companies: Zentalis Pharmaceuticals (ZNTL), Inhibikase Therapeutics (IKT) and Intra-Cellular Therapies (ITCI)
• June 18 ·

  Seeking Alpha
  Inhibikase Therapeutics files to sell 4.76M shares of common stock for holders
• June 17 ·

  Yahoo
  Inhibikase Therapeutics Completes Enrollment of the Phase 2 ‘201’ Trial Evaluating Risvodetinib in Untreated Parkinson’s Disease